Antonio Lopez Gambero
Post-Doctoral Researcher
/ Contact
www.orcid.org/0000-0001-7716-9056
Scientific articles
-
Therapeutic Efficacy of the Inositol D-Pinitol as a Multi-Faceted Disease Modifier in the 5×FAD Humanized Mouse Model of Alzheimer’s Amyloidosis
Nutrients. 2024-12-04. 16(23) : 4186.
10.3390/nu16234186 -
A sympathetic brake on gut GLP-1 release
Neuron. 2024-03-01. 112(6) : 865-867.
10.1016/j.neuron.2024.02.015 -
mTORC1 in energy expenditure: consequences for obesity
Nat Rev Endocrinol. 2024-01-15.
10.1038/s41574-023-00934-0 -
Pharmacokinetics and Endocrine Effects of an Oral Dose of D-Pinitol in Human Fasting Healthy Volunteers
Nutrients. 2022-10-01. 14(19) : 4094.
10.3390/nu14194094 -
Endocrine and Metabolic Impact of Oral Ingestion of a Carob-Pod-Derived Natural-Syrup-Containing D-Pinitol: Potential Use as a Novel Sweetener in Diabetes
Pharmaceutics. 2022-07-30. 14(8) : 1594.
10.3390/pharmaceutics14081594 -
d ‐Pinitol promotes tau dephosphorylation through a cyclin‐dependent kinase 5 regulation mechanism: A new potential approach for tauopathies?
British J Pharmacology. 2022-07-18. 179(19) : 4655-4672.
10.1111/bph.15907 -
A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer’s Disease, the 5XFAD Mouse
IJMS. 2021-05-20. 22(10) : 5365.
10.3390/ijms22105365 -
Recombinant IGF-1 Induces Sex-Specific Changes in Bone Composition and Remodeling in Adult Mice with Pappa2 Deficiency
IJMS. 2021-04-14. 22(8) : 4048.
10.3390/ijms22084048 -
Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity
Biology. 2020-11-05. 9(11) : 377.
10.3390/biology9110377 -
The Biomedical Uses of Inositols: A Nutraceutical Approach to Metabolic Dysfunction in Aging and Neurodegenerative Diseases
Biomedicines. 2020-08-20. 8(9) : 295.
10.3390/biomedicines8090295 -
Energy sensors in drug addiction: A potential therapeutic target
Addiction Biology. 2020-07-07. 26(2)
10.1111/adb.12936 -
Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
Front. Pharmacol.. 2020-05-27. 11
10.3389/fphar.2020.00730 -
Differential hepatoprotective role of the cannabinoid CB1 and CB2 receptors in acetaminophen‐induced liver injury
Br J Pharmacol. 2020-04-15. 177(14) : 3309-3326.
10.1111/bph.15051 -
Epicardial cell lineages and the origin of the coronary endothelium
The FASEB Journal. 2020-02-18. 34(4) : 5223-5239.
10.1096/fj.201902249RR -
The adiponectin promoter activator NP-1 induces high levels of circulating TNFα and weight loss in obese (fa/fa) Zucker rats
Sci Rep. 2018-06-29. 8(1)
10.1038/s41598-018-27871-7 -
Brain Glucose-Sensing Mechanism and Energy Homeostasis
Mol Neurobiol. 2018-05-24. 56(2) : 769-796.
10.1007/s12035-018-1099-4 -
SVCT2 Expression and Function in Reactive Astrocytes Is a Common Event in Different Brain Pathologies
Mol Neurobiol. 2017-09-23. 55(7) : 5439-5452.
10.1007/s12035-017-0762-5